PhRMA Urges CMS to Reconsider Pricing Model and Support PDP Market Stability for Medicare Part D
2026-04-10
PubComNonGov2026-04-10
Carter Struck
WASHINGTON, April 10 -- The Pharmaceutical Research and Manufacturers of America (PhRMA) has submitted a public comment letter to the Centers for Medicare & Medicaid Services (CMS) regarding the Advan . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, April 10 -- The Pharmaceutical Research and Manufacturers of America (PhRMA) has submitted a public comment letter to the Centers for Medicare & Medicaid Services (CMS) regarding the Advan . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
Copyright © Targeted News Service, 2026